Can Taking Doxycycline Prevent Type 2 Diabetes?

Stony Brook seeks volunteers with pre-diabetes for three-month clinical trial

STONY BROOK, N.Y., February 5, 2014 – For obese individuals who are insulin-resistant and therefore prone to developing type 2 diabetes, taking low dose doxycycline may reduce the risk of developing diabetes. The Stony Brook Medicine “Doxycycline for treatment of insulin resistance in obesity” study is seeking participants for the three-month clinical trial. Compensation for volunteers is up to $450.  https://news.stonybrook.edu/newsroom/press-release/medical/140205doxy/

Subscribe to Our Newsletter

Stay connected with reflections on faith, reason, and life.

No spam. Unsubscribe anytime.

We don’t spam! Read our privacy policy for more info.

Similar Posts

Share Your Thoughts